Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil for perioperative analgesia in elderly total knee arthroplasty
ChiCTR2500110299Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in knee osteoarthritis (OA) (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: Quality of Recovery-15 (QoR-15) score at 24 hours postoperatively and Extubation time. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2500110299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110299.